David Hickman
13Patents
4h-index
21Co-inventors
56Inventor score
Filing activity: Jul 30, 2004 → Apr 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7772375B2 | Monoclonal antibodies that recognize epitopes of amyloid-beta | Physics | 43 | Active |
| US9241988B2 | Disaccharide synthetic lipid compounds and uses thereof | Human Necessities | 11 | Active |
| US8663650B2 | Methods and compositions comprising supramolecular constructs | Chemistry; Metallurgy | 7 | Active |
| US9687447B2 | Method for preparing liposome-based constructs | Emerging Cross-Sectional Technologies | 6 | Active |
| US7807171B2 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | Human Necessities | 4 | Expired |
| US8926983B2 | Method for improving memory in AD patients | Chemistry; Metallurgy | 3 | Expired |
| US9289488B2 | Vaccine engineering | Physics | 3 | Active |
| US9518078B2 | Disaccharide synthetic lipid compounds and uses thereof | Human Necessities | 2 | Active |
| US9975946B2 | Antibodies obtainable using supramolecular constructs | Chemistry; Metallurgy | 2 | Active |
| US8409580B2 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | Human Necessities | 2 | Active |
| US10143744B2 | Disaccharide synthetic lipid compounds and uses thereof | Human Necessities | 2 | Active |
| US11591377B2 | Heterologous administration of tau vaccines | Human Necessities | 1 | Active |
| US11958889B2 | Compositions of phosphorylated tau peptides and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.